Similarly, between the group diagnosed with clinically significant cancer and the group with either clinically insignificant cancer or no cancer, there were no significant differences in corrected PSA (20.9 ± 9.33 vs. 22.5 ± 19.2, p = 0.676) and corrected PSAD (0.507 ± 0.319 vs. 0.332 + 0.253, p = 0.0576). Here, KLK3 is linked to cancer.